Auditory Control Enhancement (ACE) in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

December 18, 2024

Study Completion Date

December 18, 2024

Conditions
Auditory Hallucinations
Interventions
DEVICE

Transcranial Direct Current Stimulation (tDCS)

tDCS will be administered using the Starstim system. We will use the freely available Simulation of Non-Invasive Brain Stimulation (SimNIBS) software to optimally target the rVLPFC and left TPJ in each subject. Finite element models will be generated using T1 and T2 scans. We will generate multiple models to maximize on-target stimulation and minimize off-target stimulation, as determined by ratio of the summed current density within and beyond target regions of interest (ROIs). tDCS current in the active stimulation condition will be maintained at 2.0 milliamps (mA) for the first 45 minutes of each one-hour training session. Sham stimulation the same current, only the current will be ramped down to 0 mA after 30 seconds. Our previous research has shown this method to produce indistinguishable skin sensation. During tDCS, patients will be monitored for possible negative side effects.

BEHAVIORAL

Auditory Cognitive Control Training (ACCT)

ACCT incorporates a subset of components from Cognitive Enhancement Therapy found to have early benefits on the cognitive deficits of interest to the proposed studies and can be conducted more time-efficiently to achieve our specific goals. ACCT involves approximately 3 hours of computerized neurocognitive training using cognitive control and processing speed training software developed by Ben-Yishay and colleagues. Deficits in cognitive control are addressed with computer training exercises containing simple stimuli with little inherent emotional or motivational salience. ACCT requires individuals to be vigilant, inhibit irrelevant stimuli, and shift attention between auditory and visual modalities. Computer training exercises facilitate reaction time in a temporal mode using auditory cues (The Attention Reaction Conditioner), spatial focusing with visual cues (the Zero Accuracy Conditioner), and temporal vigilance with auditory and visual cues (Time Estimates).

Trial Locations (1)

15213

Western Psychiatric Hospital of UPMC, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Brian A Coffman, PhD

OTHER

NCT06155695 - Auditory Control Enhancement (ACE) in Schizophrenia | Biotech Hunter | Biotech Hunter